GSK To Put Up To $7.2B Into Biotech VC’s Pipeline

0
63

Biondi stated the collaboration is part of the venture capital company’s “Innovation Supply Chain Partnership model,” developed to create and develop breakthrough medicines by forming strategic partnerships with pharmaceutical companies.